Journal of Cosmetic Research and Trichology

Dr Byung Chull An

Ph.D

Affiliation: Cell Biotech Co, Ltd, Republic of Korea
Department: Medical School
University: Chonnam National University Medical School
Email: bcan@cellbiotech.com
Country: South Korea

Dr. Byung Chull An received his Ph.D. in Biomaterials Engineering from Korea University in 2010. He completed postdoctoral training at UMass Medical School (USA) and the Korea Research Institute of Bioscience and Biotechnology before serving as an Assistant Professor at Chonnam National University Medical School. He is currently a Senior Researcher at Cell Biotech Co., Ltd. His research focuses on probiotic-based therapeutics, biomaterials, drug delivery systems, skin regeneration, cosmetic biotechnology, epidermal growth factor (EGF), stem cell biology, cancer therapeutics, and microbiome-based biomedical applications. He has published more than 47 scientific papers and holds multiple Korean and U.S. patents.

Senior Researcher, Cell Biotech Co., Ltd.
Former Assistant Professor, Chonnam National University Medical School.
Former Postdoctoral Fellow, UMass Medical School (USA).
Former Postdoctoral Fellow, Korea Research Institute of Bioscience and Biotechnology.
Developer of probiotic-based drug delivery systems.
Principal investigator of multidisciplinary biotechnology research.
Holder of 18 Korean patents and 1 U.S. patent.
Author of 47 peer-reviewed publications.
Presenter at international microbiology and biotechnology conferences.
Recipient of Best Paper Presentation Award and Best Oral Presentation Award.

Cosmetic Upgrade of EGF: Genetically Modified Probiotic-Derived Cell-Free Supernatants Containing Human EGF Protein Exhibit Diverse Biological Activities. Cosmetics (2025).
Probiotic-Derived P8 Protein: Promoting Proliferation and Migration in Stem Cells and Keratinocytes. International Journal of Stem Cells (2025).
Development for Probiotics Based Insulin Delivery System. Current Issues in Molecular Biology (2025).
Production of Active Single-Chain Insulin in E. coli: No PTM for Insulin Activation. International Journal of Peptide Research and Therapeutics (2025).
Identification of Bioactive Substances Derived from the Probiotic-Induced Bioconversion of Lagerstroemia speciosa Leaf Extract That Have Beneficial Effects on Diabetes and Obesity. Microorganisms (2024).
Anti-Cancer Roles of Probiotic-Derived P8 Protein in Colorectal Cancer Cell Line DLD-1. International Journal of Molecular Sciences (2023).
Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug. Drug Design, Development and Therapy (2021).
A Synthetic Probiotic Engineered for Colorectal Cancer Therapy Modulates Gut Microbiota. Microbiome (2021).
Colorectal Cancer Therapy Using a Pediococcus pentosaceus SL4 Drug Delivery System Secreting Lactic Acid Bacteria-Derived Protein P8. Molecules and Cells (2019).

Journal of Cosmetic Research and Trichology

Dr Byung Chull An

Publication Standards

Flyer Image

Journal Highlights

Recommended Journals

About Confseries

Useful Links

Contact Information

Quick Links